fundvisualizer.com

Nuveen Multi Cap Value ANQVAX

Performance (before sales charge)

As of 03/31/2024

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 02/29/2024
Stock
90.70%
Non-U.S. Stock
9.18%
Bond
0.00%
Non-U.S. Bond
0.00%
Preferred
0.00%
Convertible
0.00%
Cash
0.12%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 02/29/2024

Basic materials

4.57%

Consumer cyclical

6.06%

Financial services

19.77%

Real estate

3.76%

Consumer defensive

5.40%

Health care

13.68%

Utilities

4.68%

Communication services

6.11%

Energy

10.17%

Industrials

13.96%

Technology

11.70%

Top 10 holdings

As of 02/29/2024

Shell PLC ADR (Representing - Ordinary Shares)
3.48%
General Motors Co
2.98%
Flowserve Corp
2.97%
Wells Fargo & Co
2.93%
nVent Electric PLC
2.81%
Walmart Inc
2.78%
General Dynamics Corp
2.75%
JPMorgan Chase & Co
2.68%
Kenvue Inc
2.63%
DuPont de Nemours Inc
2.58%
Fund assets

$404.21 Million

Share class

A

Morningstar category

Mid-Cap Value

Expense ratio

1.23%

Investment objective

Growth

Documents